Linköping University (LiU)
LiU will participate in work packages 4 (“Evaluating the potential of novel therapeutic drugs in preclinical models for the 7 REDs”) and 7 (“Ethics and regulatory matters”). In WP4, models of the rare eye diseases aniridia, EEC, and corneal neovascularization will be used to evaluate new and repurposed compounds for therapeutic effect, providing preclinical data to support applications for first-in-human clinical studies.
In WP7, LiU will coordinate the ethical and regulatory aspects of the project in collaboration with external ethical and regulatory advisors, aiming to navigate the complex ethical and regulatory pathways in developing new drugs for rare eye diseases and obtaining approvals for human use.
Interested in Restore vision?
Restore vision, is a consumer-oriented non-profit organisation, founded to make the science behind food and health more accessible and easier to understand among the public.